Cipla Saga - Did The Doctor Prescribe A Sale?

There is a buzz again that Cipla is toying with the idea of selling out to private-equity firms Baring Asia and Blackstone, at least partially, if not seeking a full exit. In this episode of The Morning Brief, Vikas Dandekar, Editor - Pharma and Life Sciences at ET Prime, walks down memory lane.
Host Anupriya Nair also discussed in this episode why the speculated Cipla sale is not a mere M&A deal and what could be on the mind of founder Yusuf Hamied. But emotions aside, do the valuations add up to excite investors? ET's Arijit Barman gives us the buzz from the deal makers. Tune in!

You can check out more episodes of The Morning Brief on: The Uncertain Fate Of Asia’s Largest Refinery, Has milk politics turned sour in Karnataka?, El Niño: Little Boy, Big Trouble, E-20 Explained: The blender’s pride or bane? And more.

If you like this episode from Anupriya Nair, you can check out more episodes of The Morning Brief Cheeni Kum: The Bitter Truth of Aspartame, Battle of the bikes: Harley Davidson vs Royal Enfield, Tomato Tangle: Deciphering India’s Tomatoflation and more. 

You can follow our host Anupriya Nair on social media Twitter & Linkedin

Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Google Podcasts.

All clips used in the episode are mentioned in the description

See omnystudio.com/listener for privacy information.